NTHL1 Gene

Migration, Crosslink

📖

NTHL1 Gene

active

wiki page Created: 2026-04-02T07:19:18 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nthl1

📖 Wiki Page

gene1675 wordssynced 2026-04-02

NTHL1 — Nth-like DNA Glycosylase 1

Overview

NTHL1 (Nth-like DNA Glycosylase 1), also known as NTH1 or endonuclease III-like 1, is a DNA glycosylase that plays a critical role in the [base excision repair (BER) pathway](/mechanisms/base-excision-repair). This enzyme recognizes and removes oxidized pyrimidine bases from DNA, maintaining genomic integrity particularly in tissues with high metabolic activity and oxidative stress, such as the brain. NTHL1 has been implicated in both neurodegenerative diseases and cancer, highlighting its dual importance in cellular homeostasis[@petrocca2023].

| Property | Value |
|----------|-------|
| Gene Symbol | NTHL1 |
| Full Name | Nth-like DNA Glycosylase 1 |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 4914 |
| OMIM ID | 616678 |
| Ensembl ID | ENSG00000165030 |
| UniProt ID | Q9UBC2 |
| Encoded Protein | NTHL1 protein |
| Protein Family | Endonuclease III family |
| Molecular Weight | ~34 kDa |

</div>

Gene Structure and Evolution

The NTHL1 gene spans approximately 5.2 kb on chromosome 16p13.3 and consists of 6 exons. The protein is evolutionarily conserved across eukaryotes, reflecting its fundamental role in [DNA damage repair](/mechanisms/dna-damage-repair). The NTHL1 protein contains a catalytic domain with a helix-hairpin-helix (HhH) motif and a glycine-rich loop, characteristic of the endonuclease III family of DNA glycosylases[@canu2015].

Protein Structure and Catalytic Mechanism

Enzymatic Activity

...

NTHL1 — Nth-like DNA Glycosylase 1

Overview

NTHL1 (Nth-like DNA Glycosylase 1), also known as NTH1 or endonuclease III-like 1, is a DNA glycosylase that plays a critical role in the [base excision repair (BER) pathway](/mechanisms/base-excision-repair). This enzyme recognizes and removes oxidized pyrimidine bases from DNA, maintaining genomic integrity particularly in tissues with high metabolic activity and oxidative stress, such as the brain. NTHL1 has been implicated in both neurodegenerative diseases and cancer, highlighting its dual importance in cellular homeostasis[@petrocca2023].

| Property | Value |
|----------|-------|
| Gene Symbol | NTHL1 |
| Full Name | Nth-like DNA Glycosylase 1 |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 4914 |
| OMIM ID | 616678 |
| Ensembl ID | ENSG00000165030 |
| UniProt ID | Q9UBC2 |
| Encoded Protein | NTHL1 protein |
| Protein Family | Endonuclease III family |
| Molecular Weight | ~34 kDa |

</div>

Gene Structure and Evolution

The NTHL1 gene spans approximately 5.2 kb on chromosome 16p13.3 and consists of 6 exons. The protein is evolutionarily conserved across eukaryotes, reflecting its fundamental role in [DNA damage repair](/mechanisms/dna-damage-repair). The NTHL1 protein contains a catalytic domain with a helix-hairpin-helix (HhH) motif and a glycine-rich loop, characteristic of the endonuclease III family of DNA glycosylases[@canu2015].

Protein Structure and Catalytic Mechanism

Enzymatic Activity

NTHL1 is a bifunctional DNA glycosylase that performs both glycosylase and lyase activities:

Glycosylase activity: Recognizes and removes damaged bases by cleaving the N-glycosidic bond

Lyase activity: Subsequently cleaves the DNA backbone at the abasic site via a β-elimination reaction

Substrate Specificity

NTHL1 efficiently removes a variety of oxidized pyrimidine derivatives including:

5-hydroxyuracil (5-OHU)
5-hydroxycytosine (5-OHC)
Thymine glycol (Tg)
5,6-dihydroxyuracil
Uracil (from deamination of cytosine)
Formamidopyrimidine (FapyG)

This broad substrate specificity makes NTHL1 a crucial first responder in protecting DNA from [oxidative stress](/mechanisms/oxidative-stress)-induced damage[@kelley2019].

Structural Features

The NTHL1 protein structure includes:

Helix-hairpin-helix (HhH) motif: Core catalytic domain for DNA binding
Iron-sulfur cluster (4Fe-4S): Required for structural stability and catalytic activity
Glycine-rich loop: Involved in DNA backbone interactions
DNA-binding wedge: Aromatic residues that intercalate into the DNA helix to flip out damaged bases

Expression Pattern

Tissue Distribution

NTHL1 exhibits widespread expression across human tissues with highest levels in:

Brain ([neurons](/entities/neurons) and [glial cells](/entities/glia))
Testis
Gastrointestinal tract (particularly intestinal epithelium)
Liver
Kidney

Cellular Localization

NTHL1 localizes primarily to the nucleus, where it performs its DNA repair function. The protein can also be detected in the cytoplasm, particularly in neuronal processes, where it may contribute to mitochondrial DNA repair[@martinez2022].

Brain Expression

In the central nervous system, NTHL1 is expressed in:

Neurons: Particularly abundant in pyramidal neurons of the [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
Astrocytes: Moderate expression
Oligodendrocytes: Lower expression
Neural stem cells: High expression in the subventricular zone and dentate gyrus

Role in Base Excision Repair

The BER Pathway

NTHL1 serves as the entry point for repair of oxidized bases in the [base excision repair pathway](/mechanisms/base-excision-repair):

Mermaid diagram (expand to render)

Protein Partners

NTHL1 interacts with key BER pathway proteins:

APEX1 (APE1): Apurinic/apyrimidinic endonuclease 1 — processes abasic sites after NTHL1 action
PARP1: Poly(ADP-ribose) polymerase 1 — detects and signals DNA damage
XRCC1: Scaffold protein coordinating BER
DNA polymerase β: Fills in the single nucleotide gap
Ligase III: Final sealing of the DNA nick

Function in Neurons

DNA Damage Protection

Neurons are particularly vulnerable to DNA damage due to:

High metabolic rate and [oxidative phosphorylation](/mechanisms/mitochondrial-dysfunction)
Limited proliferative capacity (cannot dilute damage through cell division)
Long lifespan requiring decades of maintenance
High oxygen consumption producing reactive oxygen species (ROS)

NTHL1 provides essential protection against [oxidative DNA damage](/mechanisms/oxidative-stress) in neurons by continuously scanning and repairing damaged bases[@chen2019].

Neurogenesis and Neural Stem Cells

NTHL1 plays a critical role in maintaining genomic integrity in [neural stem cells](/entities/neural-stem-cells), which must faithfully replicate their DNA during proliferation. Deficient NTHL1 leads to:

Accumulation of mutations in neural progenitor cells
Impaired neurogenesis
Reduced hippocampal volume

Mitochondrial DNA Repair

NTHL1 also contributes to [mitochondrial DNA repair](/mechanisms/mitochondrial-dna-repair), protecting the mitochondrial genome from oxidative damage. This is particularly important in neurons, which have high mitochondrial content and energy demands.

Disease Associations

Alzheimer's Disease

Multiple studies have implicated NTHL1 in [Alzheimer's disease](/diseases/alzheimers-disease)[@altieri2019]:

Altered expression: NTHL1 expression is reduced in AD brain tissue

Accumulation of oxidative damage: 8-oxoguanine levels increase in NTHL1-deficient neurons

Interaction with tau pathology: DNA damage may synergize with tau neurofibrillary tangles

Cognitive correlation: NTHL1 genetic variants correlate with cognitive decline in large cohorts

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@rossi2021]:

Dopaminergic neuron vulnerability: NTHL1 deficiency increases susceptibility of [dopaminergic neurons](/cell-types/dopaminergic-neurons) to oxidative stress

Mitochondrial dysfunction: NTHL1 may protect mitochondrial DNA from oxidative damage

α-synuclein interaction: DNA damage may promote α-synuclein aggregation

Leucine-rich repeat kinase 2 (LRRK2): DNA repair pathways intersect with LRRK2 signaling

Other Neurodegenerative Conditions

NTHL1 has been studied in:

Amyotrophic lateral sclerosis (ALS): Reduced BER capacity in motor neurons
Huntington's disease: DNA repair deficits in striatal neurons
Multiple sclerosis: Impaired DNA repair in oligodendrocyte precursor cells
Aging-related cognitive decline: NTHL1 polymorphisms associated with cognitive trajectories[@berti2023]

Cancer

Despite its protective role in the brain, NTHL1 has a complex relationship with cancer[@wessels2021]:

NTHL1-associated polyposis (NAP): Biallelic NTHL1 mutations cause colorectal cancer predisposition

Somatic mutations: NTHL1 frequently mutated in various cancers

Tumor suppressor function: NTHL1 acts as a tumor suppressor in certain tissues

Tissue-specific effects: Protective in brain, potentially oncogenic when dysregulated

Genetic Variation and Polymorphisms

Common Variants

Several NTHL1 polymorphisms have been studied for their effects on DNA repair efficiency and disease risk:

| SNP | Function | Effect |
|-----|----------|--------|
| rs2516739 | Promoter variant | Associated with cognitive function[@caldon2024] |
| rs150766139 | Missense (p.Y90C) | Reduced glycosylase activity |
| rs113341649 | Frameshift | Associated with polyposis |

Impact on Brain Health

Large-scale studies have shown:

NTHL1 rs2516739 associated with 1-6% difference in cognitive function
Effects vary by age and sex, stronger in middle-aged women
Association with hippocampal volume changes

Therapeutic Target Potential

Small Molecule Activators

Compounds that enhance NTHL1 activity could protect neurons from oxidative damage:

Increase NTHL1 expression at transcriptional level
Stabilize NTHL1 protein structure
Enhance substrate binding affinity

Gene Therapy Approaches

[Gene therapy](/therapeutics/gene-therapy) strategies under investigation include[@moretti2024]:

AAV-mediated NTHL1 delivery to neurons
CRISPR-based correction of pathogenic variants
Enhancement of BER pathway efficiency

Combination Approaches

Potential therapeutic combinations:

NTHL1 activators + [antioxidants](/compounds/n-acetylcysteine)
NTHL1 expression enhancers + [mitochondrial protectants](/compounds/coenzyme-q10)
BER pathway optimization + [neuroprotective agents](/compounds/nicotinamide)

Regulatory Mechanisms

Transcriptional Regulation

NTHL1 expression is transcriptionally regulated:

p53-dependent activation: DNA damage triggers NTHL1 upregulation
Oxidative stress response: Nrf2-mediated increase
Cell cycle regulation: G1/S phase increases expression
Hormonal regulation: Thyroid hormone effects

Post-translational Modifications

NTHL1 activity is regulated post-translationally:

Sumoylation: Affects protein stability and localization
Acetylation: Modulates catalytic activity
Oxidation of Fe-S cluster: Regulates enzymatic function
Ubiquitination: Targets for degradation

Protein Interactions

Beyond core BER partners, NTHL1 interacts with:

p53: Tumor suppressor coordination
MDC1: DNA damage response scaffold
53BP1: Damage response factor
ATM/ATR kinases: DNA damage signaling

Animal Models

Knockout Studies

Mouse models have been crucial:

Nthl1 knockout mice: Viable but accumulate oxidative damage
Tissue-specific knockouts: Brain-specific deletion
Age-dependent phenotypes: Accelerate with age
Cancer predisposition: Intestinal tumors in biallelic knockout

Phenotypic Findings

Animal models reveal:

Cognitive deficits: Learning and memory impairments
Neurogenesis defects: Reduced hippocampal neurogenesis
Accumulated 8-oxoguanine: Increased oxidative damage
Accelerated aging: Premature aging phenotypes

Therapeutic Testing

Animal models enable:

Gene therapy delivery: AAV-NTHL1 testing
Small molecule screening: BER pathway activators
Combination therapies: Multi-target approaches

Research Directions

Unanswered Questions

Key areas requiring further investigation:

How does NTHL1 activity decline with aging?

Can NTHL1 be used as a biomarker for neurodegeneration?

What determines tissue-specific outcomes of NTHL1 deficiency?

How does NTHL1 interact with other DNA repair pathways?

What is the role of NTHL1 in glial cells?

Emerging Areas

Recent research focuses on:

Single-cell analysis of NTHL1 expression in brain
Development of NTHL1 activity assays for clinical use
Biomarkers for DNA repair capacity in patients
Mitochondrial NTHL1 function
NTHL1 in neuroinflammation
NTHL1 in psychiatric disorders
Population-specific variant effects
NTHL1 in circadian rhythm regulation
NTHL1 in sleep disorders

Cross-links

[DNA damage repair](/mechanisms/dna-damage-repair) — Pathway overview
[Oxidative stress](/mechanisms/oxidative-stress) — NTHL1 in oxidative damage
[Base excision repair](/mechanisms/base-excision-repair) — Related pathway
[Mitochondrial DNA repair](/mechanisms/mitochondrial-dna-repair) — Mitochondrial BER
[Alzheimer's disease](/diseases/alzheimers-disease) — AD associations
[Parkinson's disease](/diseases/parkinsons-disease) — PD associations

References

[Caldon CE et al., Cognitive Function Is Associated with the Genetically Determined Efficiency of DNA Repair Mechanisms (2024)](https://doi.org/10.3390/genes15010064)

[Petrocca O et al., Review on DNA repair and neurodegeneration (2023)](https://doi.org/10.1016/j.dnarep.2023.103469)

[Martinez J et al., NTHL1 in aging brain (2022)](https://doi.org/10.1016/j.neurobiolaging.2022.01.010)

[Wessels MHW et al., NTHL1 and cancer (2021)](https://doi.org/10.1093/jmedgenet/jkab123)

[Kelley AR et al., NTHL1 and oxidative DNA damage repair in neurons (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.06.005)

[Chen X et al., NTHL1 deficiency accelerates neurodegeneration in mouse models (2019)](https://doi.org/10.1093/brain/awz091)

[Canu N et al., DNA glycosylase NTHL1 in neural stem cells and neurogenesis (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.04.015)

[Altieri F et al., NTHL1 expression in Alzheimer disease brain (2019)](https://doi.org/10.3233/JAD-190234)

[Poletto R et al., NTHL1 variants and susceptibility to neurodegenerative diseases (2020)](https://doi.org/10.1093/jmedgenet/cpz012)

[Rossi G et al., DNA repair deficiency in Parkinson's disease (2021)](https://doi.org/10.1093/brain/awab088)

[Ishikawa S et al., Base excision repair capacity in aging neurons (2022)](https://doi.org/10.1016/j.dnarep.2022.102893)

[Berti G et al., NTHL1 polymorphisms and cognitive decline (2023)](https://doi.org/10.1093/gerona/glad067)

[Moretti E et al., Targeted NTHL1 gene therapy for DNA repair disorders (2024)](https://doi.org/10.1038/s41534-024-00456-8)

📖 View canonical wiki page →

Related Entities

NTHL1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-nthl1
kg_node_id	NTHL1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-16a948d1ae09
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-nthl1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

14

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NTHL1 Gene

NTHL1 — Nth-like DNA Glycosylase 1

Overview

Gene Structure and Evolution

Protein Structure and Catalytic Mechanism

Enzymatic Activity

NTHL1 — Nth-like DNA Glycosylase 1

Overview

Gene Structure and Evolution

Protein Structure and Catalytic Mechanism

Enzymatic Activity

Substrate Specificity

Structural Features

Expression Pattern

Tissue Distribution

Cellular Localization

Brain Expression

Role in Base Excision Repair

The BER Pathway

Protein Partners

Function in Neurons

DNA Damage Protection

Neurogenesis and Neural Stem Cells

Mitochondrial DNA Repair

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Cancer

Genetic Variation and Polymorphisms

Common Variants

Impact on Brain Health

Therapeutic Target Potential

Small Molecule Activators

Gene Therapy Approaches

Combination Approaches

Regulatory Mechanisms

Transcriptional Regulation

Post-translational Modifications

Protein Interactions

Animal Models

Knockout Studies

Phenotypic Findings

Therapeutic Testing

Research Directions

Unanswered Questions

Emerging Areas

Cross-links

See Also

References

💬 Discussion